David Moller
Plus aucun poste en cours
Profil
David E.
Moller formerly worked at Eli Lilly & Co., as Vice President-Endocrine & Cardiovascular Research, Merck & Co., Inc., as Vice President-Metabolic Disorders, Poxel SA, as Chief Scientific Officer & Executive VP, Harvard Medical School, as Assistant Professor, and Sigilon Therapeutics, Inc., as Chief Scientific Officer.
Dr. Moller received his undergraduate degree from Brown University and doctorate degree from the University of Cincinnati (Ohio).
Anciens postes connus de David Moller
| Sociétés | Poste | Fin |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| POXEL | Chief Tech/Sci/R&D Officer | - |
Formation de David Moller
| Brown University | Undergraduate Degree |
| University of Cincinnati (Ohio) | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| POXEL | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
